| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Australia | 2 | |
| #3 | United States | 2 | |
| #4 | Canada | 1 | |
| #5 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Fermentation | |
| #5 | Microorganisms | |
| #6 | Heterocyclic compounds | |
| #7 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Omura Satoshi | 8 |
| #2 | Tomoda Hiroshi | 6 |
| #3 | Tanaka Haruo | 3 |
| #4 | Ohmura Satoshi | 3 |
| #5 | Komiyama Kanki | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP1375639A1 | Selection media for beauveriolide i or beauveriolide iii and process for selectively producing these substances | |
| US6818422B2 | Substances K97-0239 and process for producing the same | |
| US6482412B1 | Polypeptide having human HIV inhibitory activity, a gene encoding the polypeptide, a method to produce the polypeptide |